Healthcare provider profile · identity verified

Arthur L Stevens, M.D.

Internal Medicine · SCHENECTADY, NY · NPI 1740211515

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	912	153
Atorvastatin Calcium	Atorvastatin Calcium	893	183
Omeprazole	Omeprazole	534	103
Lisinopril	Lisinopril	497	108
Amlodipine Besylate	Amlodipine Besylate	479	104
Famotidine	Famotidine	332	54
Simvastatin	Simvastatin	322	71
Metformin Hcl	Metformin Hcl	320	64
Tamsulosin Hcl	Tamsulosin Hcl	267	49
Losartan Potassium	Losartan Potassium	194	59
Metoprolol Succinate	Metoprolol Succinate	191	43
Rosuvastatin Calcium	Rosuvastatin Calcium	179	55
Trazodone Hcl	Trazodone Hcl	162	22
Furosemide	Furosemide	138	29
Metformin Hcl Er	Metformin Hcl	123	29
Sertraline Hcl	Sertraline Hcl	118	27
Gabapentin	Gabapentin	109	31
Fenofibrate	Fenofibrate Nanocrystallized	104	19
Hydrochlorothiazide	Hydrochlorothiazide	104	32
Pravastatin Sodium	Pravastatin Sodium	103	20
Levetiracetam	Levetiracetam	102	18
Finasteride	Finasteride	96	20
Eliquis	Apixaban	94	22
Potassium Chloride	Potassium Chloride	93	15
Hydralazine Hcl	Hydralazine Hcl	92	12
Montelukast Sodium	Montelukast Sodium	89	13
Baclofen	Baclofen	88	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	86	18
Oxybutynin Chloride Er	Oxybutynin Chloride	81	12
Fluoxetine Hcl	Fluoxetine Hcl	69	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	67	26
Lamotrigine	Lamotrigine	67	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	63	16
Synthroid	Levothyroxine Sodium	63	18
Jardiance	Empagliflozin	62	13
Fluticasone Propionate	Fluticasone Propionate	61	21
Citalopram Hbr	Citalopram Hydrobromide	55	18
Atenolol	Atenolol	53	18
Venlafaxine Hcl Er	Venlafaxine Hcl	52	12
Alendronate Sodium	Alendronate Sodium	50	13
Escitalopram Oxalate	Escitalopram Oxalate	49	11
Trimethoprim	Trimethoprim	49	suppressed
Donepezil Hcl	Donepezil Hcl	46	suppressed
Divalproex Sodium	Divalproex Sodium	44	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	16
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	41	suppressed
Fenofibrate	Fenofibrate,micronized	40	suppressed
Midodrine Hcl	Midodrine Hcl	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Propranolol Hcl	Propranolol Hcl	34	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Meloxicam	Meloxicam	33	12
Spironolactone	Spironolactone	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	13
Linzess	Linaclotide	32	suppressed
Olanzapine	Olanzapine	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Lactulose	Lactulose	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Topiramate	Topiramate	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	19
Metoclopramide Hcl	Metoclopramide Hcl	28	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	27	suppressed
Irbesartan	Irbesartan	27	suppressed
Ozempic	Semaglutide	27	suppressed
Primidone	Primidone	27	suppressed
Allopurinol	Allopurinol	26	14
Lansoprazole	Lansoprazole	26	suppressed
Methenamine Hippurate	Methenamine Hippurate	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Glipizide	Glipizide	25	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Diazepam	Diazepam	22	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Lorazepam	Lorazepam	22	17
Memantine Hcl	Memantine Hcl	22	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Enulose	Lactulose	20	suppressed
Carbamazepine	Carbamazepine	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Prednisone	Prednisone	17	suppressed
Scopolamine	Scopolamine	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Lacosamide	Lacosamide	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Silodosin	Silodosin	16	suppressed
Zonisamide	Zonisamide	16	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Desmopressin Acetate	Desmopressin Acetate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Niacin Er	Niacin	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error